Search results
Results From The WOW.Com Content Network
Future Medicinal Chemistry is a peer-reviewed medical journal covering all aspects of medicinal chemistry, including drug discovery, pharmacology, in silico drug design, structural characterization techniques, ADME-Tox investigations, and science policy, economic and intellectual property issues. It was established in 2009 and is published by ...
SJR is developed by the Scimago Lab, [5] originated from a research group at the University of Granada. The SJR indicator is a variant of the eigenvector centrality measure used in network theory. Such measures establish the importance of a node in a network based on the principle that connections to high-scoring nodes contribute more to the ...
A study published in 2021 compared the Impact Factor, Eigenfactor Score, SCImago Journal & Country Rank and the Source Normalized Impact per Paper, in journals related to Pharmacy, Toxicology and Biochemistry. It discovered there was "a moderate to high and significant correlation" between them. [25]
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
in silico Plants (isP) is a peer-reviewed open-access, non-profit scientific journal established in 2019 [1] and publishing on all aspects of computational plant biology. The editor-in-chief is Stephen P. Long, environmental plant physiologist, Fellow of the Royal Society and member of the National Academy of Sciences (University of Illinois and Lancaster University).
The term in silico was first used in 1989 at a workshop "Cellular Automata: Theory and Applications" by a mathematician from National Autonomous University of Mexico (UNAM). [2] The term in silico radiation oncology, a precursor of generic in silico medicine was coined and first introduced by G. Stamatakos in Proceedings of the IEEE in 2002. [3]
Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, [2] with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, [3] and in New York, at The Cure by Deerfield. The company combines genomics, big data analysis, and deep learning for in silico drug ...
In biology and other experimental sciences, an in silico experiment is one performed on a computer or via computer simulation software. The phrase is pseudo-Latin for 'in silicon' (correct Latin : in silicio ), referring to silicon in computer chips.